Discuss Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
From BugSigDB
the sample sizes of the groups in experiment 2 (Progressive- Free- Survival more less than 30 days, and Progressive -Free- Survival more than 30 days) were not clearly stated. However, the experiment was carried out in the entire cohort which has sample size of 100
